BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35621728)

  • 1. Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia.
    Shi Y; Xue Y; Wang C; Yu L
    Hematology; 2022 Dec; 27(1):609-619. PubMed ID: 35621728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
    Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
    Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future perspectives in targeted therapy of NPM1-mutated AML.
    Ranieri R; Pianigiani G; Sciabolacci S; Perriello VM; Marra A; Cardinali V; Pierangeli S; Milano F; Gionfriddo I; Brunetti L; Martelli MP; Falini B
    Leukemia; 2022 Oct; 36(10):2351-2367. PubMed ID: 36008542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
    Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
    Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3.
    Jing Y; Jiang X; Lei L; Peng M; Ren J; Xiao Q; Tao Y; Tao Y; Huang J; Wang L; Tang Y; Yang Z; Yang Z; Zhang L
    J Exp Clin Cancer Res; 2021 Oct; 40(1):312. PubMed ID: 34615546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions.
    Falini B
    Am J Hematol; 2023 Sep; 98(9):1452-1464. PubMed ID: 37317978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Curious Novel Combination of
    Venanzi A; Rossi R; Martino G; Annibali O; Avvisati G; Mameli MG; Sportoletti P; Tiacci E; Falini B; Martelli MP
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573408
    [No Abstract]   [Full Text] [Related]  

  • 8. Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.
    Zarka J; Short NJ; Kanagal-Shamanna R; Issa GC
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
    Falini B
    Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of small molecule inhibitor NSC348884 on nucleophosmin 1-mutated acute myeloid leukemia cells.
    Zhu JF; Han LL; Ma Y; Wang YX; Zhang F
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9145-9151. PubMed ID: 37843328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on NPM1 gene mutations in acute myeloid leukemia].
    Chen HY; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):258-62. PubMed ID: 23484732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
    Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
    Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When the good go bad: Mutant NPM1 in acute myeloid leukemia.
    Kunchala P; Kuravi S; Jensen R; McGuirk J; Balusu R
    Blood Rev; 2018 May; 32(3):167-183. PubMed ID: 29157973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (
    Chin L; Wong CYG; Gill H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.
    Simonetti G; Mengucci C; Padella A; Fonzi E; Picone G; Delpino C; Nanni J; De Tommaso R; Franchini E; Papayannidis C; Marconi G; Pazzaglia M; Perricone M; Scarpi E; Fontana MC; Bruno S; Tebaldi M; Ferrari A; Bochicchio MT; Ghelli Luserna Di Rorà A; Ghetti M; Napolitano R; Astolfi A; Baldazzi C; Guadagnuolo V; Ottaviani E; Iacobucci I; Cavo M; Castellani G; Haferlach T; Remondini D; Capozzi F; Martinelli G
    Leukemia; 2021 Oct; 35(10):2813-2826. PubMed ID: 34193978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation.
    Cocciardi S; Dolnik A; Kapp-Schwoerer S; Rücker FG; Lux S; Blätte TJ; Skambraks S; Krönke J; Heidel FH; Schnöder TM; Corbacioglu A; Gaidzik VI; Paschka P; Teleanu V; Göhring G; Thol F; Heuser M; Ganser A; Weber D; Sträng E; Kestler HA; Döhner H; Bullinger L; Döhner K
    Nat Commun; 2019 May; 10(1):2031. PubMed ID: 31048683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
    Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
    Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin mutation in de-novo acute myeloid leukemia.
    Rastogi P; Naseem S; Varma N; Varma S
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):77-85. PubMed ID: 26669619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
    Peng M; Ren J; Jing Y; Jiang X; Xiao Q; Huang J; Tao Y; Lei L; Wang X; Yang Z; Yang Z; Zhan Q; Lin C; Jin G; Zhang X; Zhang L
    J Extracell Vesicles; 2021 Nov; 10(13):e12168. PubMed ID: 34807526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice.
    Martelli MP; Pettirossi V; Thiede C; Bonifacio E; Mezzasoma F; Cecchini D; Pacini R; Tabarrini A; Ciurnelli R; Gionfriddo I; Manes N; Rossi R; Giunchi L; Oelschlägel U; Brunetti L; Gemei M; Delia M; Specchia G; Liso A; Di Ianni M; Di Raimondo F; Falzetti F; Del Vecchio L; Martelli MF; Falini B
    Blood; 2010 Nov; 116(19):3907-22. PubMed ID: 20634376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.